What is the market size of generic drugs in India | Industry Trends & Forecast 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10684

Publication Date: Nov 2025

What is the growth rate of the India Generic Drugs Market?

According to 6Wresearch internal database and industry insights, the India Generic Drugs Market is projected to expand at a CAGR of 9.1% during the forecast period 2025-2031.

There are numbers of factors which are contributing in the expansion of the market include rising prevalence of chronic diseases, growing demand for affordable medicines, supportive government initiatives to promote local drug manufacturing, and increasing healthcare expenditure. Additionally, patent expirations of branded drugs and growing export potential are driving the market growth.

Key Growth Drivers of the India Generic Drugs Market

Rising demand for cost-effective medicines across the country
Increasing government support for domestic pharmaceutical production
Expiration of patents of branded drugs encouraging generic entry
Expanding healthcare infrastructure and insurance coverage
Growing export of generics to developed markets
Technological advancements in drug formulation and manufacturing

India Generic Drugs Market Trends

India Generic Drugs Market is witnessing notable growth trends, including the increasing shift towards high-value generics and biosimilars. There is rising investment in R&D for complex generics and injectable formulations. The market is also seeing greater regulatory harmonization, improving quality compliance, and digital transformation in supply chains. The expansion of e-pharmacy platforms and online distribution channels is boosting accessibility. Furthermore, drug companies are working on brand differentiation, portfolio diversification, and strategic partnerships to make their presence stronger in both the US and other countries.

Emerging Developments in the India Generic Drugs Market

India Generic Drugs Market is evolving with growing investment in biosimilars, novel drug delivery systems, and complex generics such as inhalers and injectables. Therefore, to make things run more smoothly, businesses are using automation, AI-driven analytics, and cutting-edge manufacturing technologies. The introduction of Production Linked Incentive (PLI) schemes for pharmaceuticals is helping to boost the production of APIs and formulations in the area. More companies and multinational companies are working together on co-marketing and licensing, which is leading to new ideas. Moreover, quality standardization and increased R&D expenditure are reshaping the competitive landscape of the market.